Saturna Capital’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.84M | Buy |
33,346
+4,184
| +14% | +$227K | 0.03% | 79 |
|
|
2025
Q4 | $1.43M | Buy |
29,162
+8,512
| +41% | +$397K | 0.02% | 86 |
|
|
2025
Q3 | $891K | Sell |
20,650
-2,008
| -9% | -$78.4K | 0.01% | 98 |
|
|
2025
Q2 | $870K | Buy |
22,658
+8
| +0% | +$306 | 0.01% | 103 |
|
|
2025
Q1 | $877K | Sell |
22,650
-2,550
| -10% | -$93.4K | 0.01% | 103 |
|
|
2024
Q4 | $852K | Sell |
25,200
-2,138
| -8% | -$77K | 0.01% | 105 |
|
|
2024
Q3 | $1.12M | Buy |
27,338
+1,888
| +7% | +$77.2K | 0.01% | 102 |
|
|
2024
Q2 | $980K | Sell |
25,450
-4,592
| -15% | -$193K | 0.01% | 110 |
|
|
2024
Q1 | $1.29M | Buy |
30,042
+630
| +2% | +$26K | 0.02% | 106 |
|
|
2023
Q4 | $1.09M | Buy |
29,412
+3,040
| +12% | +$109K | 0.02% | 107 |
|
|
2023
Q3 | $956K | Sell |
26,372
-1,240
| -4% | -$44K | 0.02% | 108 |
|
|
2023
Q2 | $984K | Buy |
27,612
+1,659
| +6% | +$59.5K | 0.02% | 107 |
|
|
2023
Q1 | $923K | Hold |
25,953
| – | – | 0.02% | 111 |
|
|
2022
Q4 | $912K | Sell |
25,953
-171,368
| -87% | -$5.71M | 0.02% | 105 |
|
|
2022
Q3 | $5.81M | Sell |
197,321
-334,591
| -63% | -$12.7M | 0.14% | 62 |
|
|
2022
Q2 | $28.9M | Buy |
531,912
+72
| +0% | +$3.98K | 0.68% | 52 |
|
|
2022
Q1 | $29M | Buy |
531,840
+88,960
| +20% | +$4.83M | 0.58% | 51 |
|
|
2021
Q4 | $24.8M | Buy |
442,880
+82,336
| +23% | +$4.28M | 0.44% | 55 |
|
|
2021
Q3 | $17.2M | Buy |
360,544
+13,594
| +4% | +$683K | 0.35% | 57 |
|
|
2021
Q2 | $17.3M | Hold |
346,950
| – | – | 0.35% | 58 |
|
|
2021
Q1 | $15.5M | Sell |
346,950
-1,416
| -0.4% | -$64.3K | 0.35% | 59 |
|
|
2020
Q4 | $16M | Sell |
348,366
-3,840
| -1% | -$176K | 0.36% | 59 |
|
|
2020
Q3 | $16.6M | Buy |
352,206
+360
| +0.1% | +$18K | 0.42% | 58 |
|
|
2020
Q2 | $17.9M | Buy |
351,846
+4,320
| +1% | +$222K | 0.5% | 56 |
|
|
2020
Q1 | $16.5M | Buy |
347,526
+10,804
| +3% | +$576K | 0.53% | 55 |
|
|
2019
Q4 | $19.8M | Buy |
336,722
+560
| +0.2% | +$31.1K | 0.54% | 56 |
|
|
2019
Q3 | $17.9M | Hold |
336,162
| – | – | 0.52% | 57 |
|
|
2019
Q2 | $16.8M | Hold |
336,162
| – | – | 0.49% | 58 |
|
|
2019
Q1 | $17.6M | Buy |
336,162
+15,172
| +5% | +$758K | 0.51% | 61 |
|
|
2018
Q4 | $15.3M | Buy |
320,990
+3,304
| +1% | +$163K | 0.52% | 60 |
|
|
2018
Q3 | $16M | Buy |
317,686
+34,080
| +12% | +$1.73M | 0.46% | 65 |
|
|
2018
Q2 | $14.3M | Hold |
283,606
| – | – | 0.46% | 66 |
|
|
2018
Q1 | $13.9M | Hold |
283,606
| – | – | 0.44% | 66 |
|
|
2017
Q4 | $12.6M | Hold |
283,606
| – | – | 0.38% | 69 |
|
|
2017
Q3 | $14.4M | Sell |
283,606
-46,234
| -14% | -$2.35M | 0.47% | 68 |
|
|
2017
Q2 | $17.8M | Sell |
329,840
-320
| -0.1% | -$17.1K | 0.59% | 64 |
|
|
2017
Q1 | $17.4M | Hold |
330,160
| – | – | 0.59% | 64 |
|
|
2016
Q4 | $15.9M | Sell |
330,160
-600
| -0.2% | -$29.6K | 0.56% | 67 |
|
|
2016
Q3 | $17.8M | Sell |
330,760
-800
| -0.2% | -$43.9K | 0.58% | 67 |
|
|
2016
Q2 | $18M | Sell |
331,560
-320
| -0.1% | -$16.9K | 0.58% | 67 |
|
|
2016
Q1 | $17.9M | Hold |
331,880
| – | – | 0.57% | 69 |
|
|
2015
Q4 | $16.7M | Hold |
331,880
| – | – | 0.52% | 75 |
|
|
2015
Q3 | $16M | Sell |
331,880
-80,000
| -19% | -$4.16M | 0.5% | 77 |
|
|
2015
Q2 | $21.4M | Sell |
411,880
-119,760
| -23% | -$6.74M | 0.6% | 72 |
|
|
2015
Q1 | $31.6M | Hold |
531,640
| – | – | 0.85% | 54 |
|
|
2014
Q4 | $28.4M | Hold |
531,640
| – | – | 0.74% | 61 |
|
|
2014
Q3 | $30.5M | Sell |
531,640
-320
| -0.1% | -$19.6K | 0.82% | 54 |
|
|
2014
Q2 | $35.6M | Hold |
531,960
| – | – | 0.93% | 47 |
|
|
2014
Q1 | $35.5M | Hold |
531,960
| – | – | 0.93% | 45 |
|
|
2013
Q4 | $35.5M | Buy |
531,960
+1,200
| +0.2% | +$77.8K | 0.91% | 49 |
|
|
2013
Q3 | $33.3M | Sell |
530,760
-3,600
| -0.7% | -$232K | 0.88% | 46 |
|
|
2013
Q2 | $33.4M | Buy |
+534,360
| New | +$33.9M | 0.91% | 43 |
|
Other funds holding GSK
JEST
